A recent JAMA article reviews the 3 most common eating disorders, their risk factors, diagnosis and treatment. In this podcast, coauthors Evelyn Attia, MD, and Timothy Walsh, MD, both from Columbia University Irving Medical Center, discuss eating disorders with JAMA Deputy Editor Kristin Walter, MD, MS. Related Content: Eating Disorders

Christopher Robertson, a law professor at Boston University and author of a pivotal article on medical malpractice, joins the discussion to unveil significant changes in the legal evaluation of medical negligence. He explains the American Law Institute's new patient-centered standard that enhances care quality. The conversation highlights shifts from traditional practices, the importance of physician communication about regret, and the potential implications for healthcare professionals across the nation. Listen in for insights on navigating the evolving landscape of medical liability.

In this insightful discussion, Zian Tseng, a Professor of Medicine at UCSF and leading authority on cardiac arrest, shares crucial insights about sudden cardiac arrest in young adults. He reveals staggering survival rates, emphasizing that only a small percentage of out-of-hospital cases result in discharge. The conversation dives into the varying causes of these incidents, the vital role of screening for families, and the careful management needed for athletes wishing to return to sports after such events. Mental health support for survivors is also highlighted.

Michaela R. Anderson, an Assistant Professor of Medicine at the University of Pennsylvania and lead author on new pulmonary rehabilitation guidelines, engages with JAMA Associate Editor David Simel. They discuss the importance of personalized pulmonary rehabilitation for chronic respiratory diseases like COPD. Topics include essential components like tailored exercise training, the role of multidisciplinary teams, and innovative approaches like tele-rehabilitation. Anderson also highlights the cost-effectiveness of these programs, especially after COPD hospitalizations.

Ayalew Tefferi, a renowned Professor of Medicine at the Mayo Clinic, shares insights on essential thrombocythemia (ET), a disorder marked by excessive platelet production. He discusses the challenges in diagnosing ET amidst potential secondary causes and highlights the importance of mutation screening. The conversation covers personalized treatment options, especially for older patients and those with extreme thrombocytosis. Additionally, Tefferi emphasizes the implications of ET on pregnancy and the potential benefits of monitoring and management to mitigate risks.

Esa M. Davis, a leading expert in family and community medicine and a member of the U.S. Preventive Services Task Force, joins the discussion to highlight the critical need for osteoporosis screening. The conversation emphasizes the importance of early detection in women aged 65 and older, and the necessity for improved screening practices for younger at-risk women and men. Davis also addresses gaps in current research and treatment protocols, advocating for enhanced methods to prevent fractures and better serve diverse populations.

Janine Austin Clayton, MD, is the Associate Director for Research on Women's Health at the NIH, dedicated to bridging knowledge gaps in women's health. She highlights the evolution of NIH policies since 1986, advocating for inclusive research that considers sex differences. Recent findings from studies like GTEC and MOTORPAC reveal crucial variations in health outcomes between genders. Clayton discusses new initiatives and funding opportunities aimed at fostering comprehensive women's health research, paving the way for personalized healthcare strategies.

Robert Kushner, a renowned author and professor at Northwestern University's Feinberg School of Medicine, dives into the latest advancements in obesity treatment. He discusses new FDA-approved medications, such as semaglutide and terzepatide, highlighting their effectiveness and side effects. Kushner emphasizes the importance of treating obesity as a chronic disease, the potential implications of stopping medication, and the need for gradual dose adjustments. This insightful conversation sheds light on the evolving landscape of obesity management.

Ian H. de Boer, a nephrology expert from the University of Washington, discusses the critical link between chronic kidney disease (CKD) and diabetes. He reveals that 30-40% of diabetic patients develop CKD and emphasizes innovative prevention strategies, including lifestyle changes and screening tests like eGFR. The conversation also covers groundbreaking treatments such as SGLT2 inhibitors and finerenone, showcasing their potential to significantly reduce CKD progression and enhance patient outcomes. Don't miss these vital insights!

Emelia J. Benjamin is a renowned Professor of Medicine and Epidemiology at Boston University and a cardiologist at Boston Medical Center. She discusses the rising prevalence of atrial fibrillation (AF) and its link to serious health risks. The conversation highlights how smartwatches can detect AF, though traditional monitoring remains essential. Emelia emphasizes the importance of managing lifestyle factors like alcohol and obesity in treating AF, along with the need for comprehensive healthcare access to improve outcomes for patients.